FDA Recalls Flower Power Female Enhancement for Undeclared Sildenafil and Tadalafil
Flower Power CBD infused Female Enhancement contains undeclared sildenafil and tadalafil. These prescription drugs were not disclosed to consumers and the product was marketed without FDA approval.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is classified as FDA Class I, which establishes a minimum severity of Severe (4). While no illnesses or injuries have been reported, the presence of undeclared prescription medications in a consumer product represents a significant health risk due to potential drug interactions and adverse effects.
Plain-English summary
Flower Power, a CBD infused female enhancement product sold in 59 ml bottles, is being recalled by the FDA due to the presence of undeclared sildenafil and tadalafil. The product, manufactured by Pyramids Wholesale Inc., was marketed and distributed nationwide without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Sildenafil and tadalafil are prescription medications used to treat erectile dysfunction. Their presence as undeclared ingredients in a consumer product poses serious health risks. Consumers taking this product may not be aware they are ingesting these potent prescription drugs, which can interact with other medications or cause adverse health effects.
The product has been distributed nationwide across the United States. The recall affects all lots of the product. Consumers who have purchased Flower Power should not use it and should consult a healthcare provider if they have already consumed the product.
The recalled product
- Product
- Flower Power, CBD infused Female Enhancement, 59 ml bottle, UPC 0 678741 351646.
- Manufacturer
- Pyramids Wholesale Inc.
- Category
- Drug — Female Enhancement
- Hazard
- undeclared-drug
- sildenafil
- tadalafil
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- HighLacosamide 100mg Tablets Recalled Due to Foreign Tablet Contamination
FDA (Drugs) · 2026-07-01
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01